India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
This certification will open new markets for the Kwality Pharma
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
BAV has revolutionized the animal vaccination industry with its ground-breaking delivery methods that prioritize quality, safety, and efficacy
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Subscribe To Our Newsletter & Stay Updated